MA51730A - Fumarate de diméthyle et régimes de vaccination - Google Patents

Fumarate de diméthyle et régimes de vaccination

Info

Publication number
MA51730A
MA51730A MA051730A MA51730A MA51730A MA 51730 A MA51730 A MA 51730A MA 051730 A MA051730 A MA 051730A MA 51730 A MA51730 A MA 51730A MA 51730 A MA51730 A MA 51730A
Authority
MA
Morocco
Prior art keywords
dimethyl fumarate
immunization regimes
regimes
immunization
fumarate
Prior art date
Application number
MA051730A
Other languages
English (en)
Inventor
Vissia Viglietta
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA51730A publication Critical patent/MA51730A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA051730A 2014-03-14 2015-03-13 Fumarate de diméthyle et régimes de vaccination MA51730A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461953259P 2014-03-14 2014-03-14

Publications (1)

Publication Number Publication Date
MA51730A true MA51730A (fr) 2020-12-16

Family

ID=52737422

Family Applications (2)

Application Number Title Priority Date Filing Date
MA039743A MA39743A (fr) 2014-03-14 2015-03-13 Fumarate de diméthyle et régimes de vaccination
MA051730A MA51730A (fr) 2014-03-14 2015-03-13 Fumarate de diméthyle et régimes de vaccination

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA039743A MA39743A (fr) 2014-03-14 2015-03-13 Fumarate de diméthyle et régimes de vaccination

Country Status (6)

Country Link
US (5) US10391160B2 (fr)
EP (2) EP3650042A1 (fr)
CA (1) CA2942690A1 (fr)
MA (2) MA39743A (fr)
MX (2) MX2016012052A (fr)
WO (1) WO2015138917A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3650042A1 (fr) 2014-03-14 2020-05-13 Biogen MA Inc. Fumarate de diméthyle et régimes de vaccination
MA40985A (fr) 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
US20190380992A1 (en) * 2014-12-04 2019-12-19 Biogen Ma Inc. Multiple Sclerosis Treatment Regimen Using Dimethyl Fumarate
AU2021208602A1 (en) * 2020-05-06 2022-12-15 Imcyse Sa Combination treatment for fumarate-related diseases
WO2021252915A1 (fr) * 2020-06-11 2021-12-16 University Of Massachusetts Succination de gasdermine d (gsdmd) pour le traitement d'une maladie inflammatoire
EP4313304A4 (fr) * 2021-03-25 2024-08-21 Univ California Compositions et méthodes d'inhibition et de traitement d'infections virales

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
PT2801355E (pt) 2004-10-08 2015-09-18 Forward Pharma As Composições farmacêuticas de libertação controlada compreendendo um éster de ácido fumárico
CN114146079A (zh) 2012-02-07 2022-03-08 比奥根玛公司 含有富马酸二甲酯的药物组合物
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
EP3110408B1 (fr) 2014-02-28 2019-01-16 Banner Life Sciences LLC Capsules molles entériques à libération contrôlée d'esters de fumarate
EP3650042A1 (fr) 2014-03-14 2020-05-13 Biogen MA Inc. Fumarate de diméthyle et régimes de vaccination
CA2962916C (fr) 2014-10-08 2021-06-15 Banner Life Sciences Llc Capsules molles enteriques a liberation controlee d'esters de fumarate
MA40985A (fr) 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
WO2017040272A1 (fr) 2015-08-31 2017-03-09 Banner Life Sciences Llc Formes posologiques d'ester de fumarate
WO2017151184A1 (fr) 2016-02-29 2017-09-08 Banner Life Sciences Llc Formes posologiques d'ester de fumarate
US10523918B2 (en) 2017-03-24 2019-12-31 Samsung Electronics Co., Ltd. System and method for depth map

Also Published As

Publication number Publication date
WO2015138917A1 (fr) 2015-09-17
US10391160B2 (en) 2019-08-27
US20220072117A1 (en) 2022-03-10
MX2022000746A (es) 2022-02-14
US20200360501A1 (en) 2020-11-19
US20170000873A1 (en) 2017-01-05
EP3650042A1 (fr) 2020-05-13
CA2942690A1 (fr) 2015-09-17
EP3116536A1 (fr) 2017-01-18
US10555993B2 (en) 2020-02-11
US20190247485A1 (en) 2019-08-15
MA39743A (fr) 2017-01-18
US20210228701A1 (en) 2021-07-29
US10994003B2 (en) 2021-05-04
MX2016012052A (es) 2017-04-27

Similar Documents

Publication Publication Date Title
DK3393510T3 (da) Zikavirusvaccine
BR112016016379A2 (pt) Implante embólico macio
DK3197354T3 (da) Medicinsk anordning
GB201410971D0 (en) Vaccine
DK3169703T3 (da) Kimær antigenreceptor og anvendelse deraf
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
IL266883A (en) Device and methods for a photobioreactor
PL3185899T3 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
DK3233903T3 (da) Kimære antigenreceptorer og anvendelsesfremgangsmåder
DE202014010318U8 (de) Wärmebehandlungsvorrichtung
FI20146023A (fi) Hammas- ja kielituki
MA51730A (fr) Fumarate de diméthyle et régimes de vaccination
IL247159B (en) Components of pcsk9
IL259743B (en) Bioreactor apparatus and methods
DK3194583T3 (da) Ikke-fucosyleret protein og fremgangsmåder dermed
DE112015001144A5 (de) Therapievorrichtung
PL3188755T3 (pl) Szczepionka
EP3161483A4 (fr) Système de test d'immunisation au point d'intervention - méthodes de détection
GB201700309D0 (en) Scanning device
FR3031032B1 (fr) Appareil de preparation culinaire
FR3031029B1 (fr) Appareil de preparation culinaire
PL3028600T3 (pl) Szczotka talerzowa i związane z nią urządzenie mocujące
GB201417214D0 (en) Vaccine
TH1601001025A (th) ตัวเร่งปฏิกิริยาอินเทอร์เอสเทอริฟิเคชัน และกรรมวิธี
GB201518917D0 (en) Vaccination